Daily News Podcast

Lorcaserin shows cardiovascular safety

Publish date: August 27, 2018

 

Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Psoriasis registry study provides more data on infliximab’s infection risk
MDedge Family Medicine
New guidelines remap adult congenital heart disease
MDedge Family Medicine
FDA approves first EpiPen generic
MDedge Family Medicine
Cardiovascular risk management supported for type 2 diabetes
MDedge Family Medicine
An epidemic of non-alcoholic fatty liver disease
MDedge Family Medicine
When your patients are your neighbors
MDedge Family Medicine
Sleepio app tied to reducing insomnia, depression
MDedge Family Medicine
5 digital HIPAA myths
MDedge Family Medicine
Screen for cervical cancer based on age, risk
MDedge Family Medicine
Is it time for PCPs to take over chronic HCV?
MDedge Family Medicine